280 results on '"Bridle, Byram W."'
Search Results
2. Adeno-associated virus mediated expression of monoclonal antibody MR191 protects mice against Marburg virus and provides long-term expression in sheep
3. AAV vectored immunoprophylaxis for filovirus infections
4. Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer
5. AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challenge
6. Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer
7. Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease
8. Disruption of type I interferon signaling causes sexually dimorphic dysregulation of anti-viral cytokines
9. Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
10. Tumour vasculature: Friend or foe of oncolytic viruses?
11. Communication between Mast Cells and Group 2 Innate Lymphoid Cells in the Skin
12. AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma
13. Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis
14. Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies
15. Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies
16. Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer
17. Beyond the Coagulation Cascade: Vitamin K and Its Multifaceted Impact on Human and Domesticated Animal Health.
18. Use of Precision-Cut Lung Slices as an Ex Vivo Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy
19. Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer
20. N-Acetylcysteine and Its Immunomodulatory Properties in Humans and Domesticated Animals
21. Dendritic Cell Vaccines Impact the Type 2 Innate Lymphoid Cell Population and Their Cytokine Generation in Mice
22. Murine Mast Cells That Are Deficient in IFNAR-Signaling Respond to Viral Infection by Producing a Large Amount of Inflammatory Cytokines, a Low Level of Reactive Oxygen Species, and a High Rate of Cell Death
23. Vitamin D Influences the Activity of Mast Cells in Allergic Manifestations and Potentiates Their Effector Functions against Pathogens
24. Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination
25. A Mathematical Model of Cytokine Dynamics During a Cytokine Storm
26. SR9009 administered for one day after myocardial ischemia-reperfusion prevents heart failure in mice by targeting the cardiac inflammasome
27. Supplementary Data Figure 2 from Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer
28. Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxis
29. The Potential of Dendritic-Cell-Based Vaccines to Modulate Type 3 Innate Lymphoid Cell Populations
30. Neutrophils in Dendritic Cell-Based Cancer Vaccination: The Potential Roles of Neutrophil Extracellular Trap Formation
31. Dendritic Cell-Based Vaccines Recruit Neutrophils to the Local Draining Lymph Nodes to Prime Natural Killer Cell Responses
32. Maraba Virus as a Potent Oncolytic Vaccine Vector
33. Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapies
34. Immunoceuticals: Harnessing Their Immunomodulatory Potential to Promote Health and Wellness
35. The Role of Neutrophils in Oncolytic Orf Virus-Mediated Cancer Immunotherapy
36. Adeno-associated virus mediated expression of monoclonal antibody MR191 protects mice against Marburg virus and provides long-term expression in sheep
37. HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy
38. Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8+ T-cell recall responses
39. Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes
40. Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine
41. ORFV: A Novel Oncolytic and Immune Stimulating Parapoxvirus Therapeutic
42. Tumor Temperature: Friend or Foe of Virus-Based Cancer Immunotherapy
43. Neutrophil Functional Heterogeneity and Implications for Viral Infections and Treatments
44. Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer
45. Potentiating Cancer Immunotherapy Using an Oncolytic Virus
46. Combining oncolytic virotherapy and tumour vaccination
47. AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma
48. How Does Severe Acute Respiratory Syndrome-Coronavirus-2 Affect the Brain and Its Implications for the Vaccines Currently in Use
49. Mast Cell Tryptase and Implications for SARS-CoV-2 Pathogenesis
50. Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.